Deep knowledge on
small-molecule drugs and
the 90,000 global patents
|Title:||Optical isomer of an imidazole derivative medetomidine as an alpha-2-receptor agonist|
|Abstract:||The separated d and l enantiomers of medetomidine and their salts are selective and potent .alpha..sub.2 -receptor agonists.|
|Inventor(s):||Karjalainen; Arto J. (Oulu, FI), Virtanen; Raimo E. (Rusko, FI), Savolainen; Eino J. (Oulu, FI)|
|Assignee:||Farmos Yhtyma Oy (Turku, FI)|
Patent Claim Types:|
see list of patent claims
|Compound; Use; Composition;|
|Foriegn Application Priority Data|
|Foreign Country||Foreign Patent Number||Foreign Patent Date|
|United Kingdom||8716803||Jul 16, 1987|
|Country||Document Number||Publication Date||Supplementary Protection Certificate||SPC Country||SPC Expiration|
|European Patent Office||0300652||Jan 22, 1992||SPC/GB03/005||United Kingdom||<disabled>|
|Ireland||60456||Jul 13, 1994|
|Denmark||165788||Jan 18, 1993|
|European Patent Office||0300652||Jan 22, 1992||C300117||Netherlands||<disabled>|
|South Africa||8805134||Apr 26, 1989|
|This preview shows a limited data set|
Subscribe for full access, or try a free trial
Export unavailable in trial.
Subscribe for complete access.
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors.
Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided information. There is no warranty that the information contained herein is error free. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.